Online Surveys to Assess the Perception and Performance of Imaging and Associated Aspects

January 16, 2024 updated by: Michael V Knopp MD PhD, University of Cincinnati

Online Surveys to Assess the Perception and Performance of Imaging Associated Aspects

In this exploratory study, the researchers would like to investigate the background, perception, current use practices, potential unmet needs and/or challenges in regard to imaging procedures, imaging technology, or any other aspect related to the broader field of imaging.

Study Overview

Status

Withdrawn

Intervention / Treatment

Detailed Description

The researchers plan to include volunteer participants to complete these surveys. The goal of these exploratory efforts will be to increase the currently very limited information available in the topics of interest stated above, and the findings, even if only from limited group of respondents, will help guide research development, prepare for design of clinical trials, guide special interest groups, and serve as role data for appropriate scientific publications.

Study Type

Observational

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Ohio
      • Columbus, Ohio, United States, 43221
        • Martha Morehouse Medical Plaza

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

The study population consists of volunteers agreeing to complete the survey tool. It is anticipated that the surveys will be completed by participants that can be considered stakeholders, such as physicians, technologist's physicists, imaging scientists, administrative staff, or others with interest in the topic.

Description

Inclusion Criteria:

  • Male and female participants who have access to the online survey tool and can read and write in English

Exclusion Criteria:

  • None, as this is voluntary

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Retrospective

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Volunteer participants
Volunteer participants will participate in surveys assessing their perception of various imaging aspects.
The investigators are recruiting health care providers for these surveys that are involved in or use imaging.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Perception of PET/CT imaging agent Y-90
Time Frame: through study completion, on average 2-5 years
To evaluate participants' perceptions of Y-90 using a likert scale on an online survey
through study completion, on average 2-5 years
Perception of PET/CT imaging agent NaF
Time Frame: through study completion, on average 2-5 years
To evaluate participants' perceptions of NaF using a likert scale on an online survey
through study completion, on average 2-5 years
Perception of MRI contrast agents
Time Frame: through study completion, on average 2-5 years
To evaluate participants' perceptions of MR contrast agents using a likert scale
through study completion, on average 2-5 years

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Michael V Knopp, MD, PhD, Ohio State University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

August 30, 2022

Primary Completion (Estimated)

December 31, 2024

Study Completion (Estimated)

December 31, 2024

Study Registration Dates

First Submitted

March 30, 2018

First Submitted That Met QC Criteria

March 30, 2018

First Posted (Actual)

April 11, 2018

Study Record Updates

Last Update Posted (Actual)

January 18, 2024

Last Update Submitted That Met QC Criteria

January 16, 2024

Last Verified

January 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • RP0320_S02/2018E0141

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Perception of Imaging

Clinical Trials on Online surveys

Subscribe